ADRD Specific Milestone
Determining the value of screening for clinically relevant cognitive impairment in the absence of a cognitive complaint.
Complete at least one practical trial of iterative (over time) cognitive impairment screening that determines the value of performing an initial cognitive assessment in middle adulthood that can serve as a baseline for future determination of meaningful change in cognitive function (a sort of “Brain Health Check” and baseline). Measure the effects that positive screenings have on the individual, family, health care system, and health care provider decision making. Complete at least one practical trial of iterative (over time) cognitive impairment screening on health disparities populations, starting during midlife, to determine the value of cognitive screening in underserved communities.
Summary of Key Accomplishments
This milestone has yet to be initiated. Accomplishments are forthcoming.
This information is current as of March 2022.
- Research Implementation Area
- AD Related Dementias - Specific
- To Be Initiated